Cited by 1,585Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesHeart Failure Treatment and Management

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Roy, Denis, Talajic, Mario, Nattel, Stanley, Wyse, D. George, Dorian, Paul, Lee, Kerry L., Bourassa, Martial G., Arnold, J. Malcolm O., Buxton, Alfred E., Camm, A. John, Connolly, Stuart J., Dubuc, Marc, Ducharme, Anique, Guerra, Peter G., Hohnloser, Stefan H., Lambert, Jean, Le Heuzey, Jean-Yves, O'Hara, Gilles, Pedersen, Ole Dyg, Rouleau, Jean-Lucien, Singh, Bramah N., Stevenson, Lynne Warner, Stevenson, William G., Thibault, Bernard, Waldo, Albert L.·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0708789

Open this paper in CoChat — free account

Abstract

BACKGROUND: It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)

Integrity signals

Registry

Crossref · 10.1056/nejmoa0708789

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citation
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426

Show all 41 references

Research works printed but not linked: 1

Carson PE, 1993, Circulation, 87, VI

Sorted by citations

Items 801–900 of 999

Evaluation of Quantitative Decision‐Making for Rhythm Management of Atrial Fibrillation Using Tabular Q‐Learning
Barrett, C. D., Suzuki, Y., Hussein, S., Garg, L., Tumolo, A. Z., Sandhu, A., West, J. J., Zipse, M. M., Aleong, R. G., Varosy, P. D., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028483 · Cited by 5
Prognostic Implications and Efficacy of Catheter Ablation by Atrial Fibrillation Type
Miyama, H., Takatsuki, S., Ikemura, N., Kimura, T., Katsumata, Y., Yamashita, S., Yamaoka, K., Ibe, S., Seki, Y., Yamashita, T., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029321 · Cited by 6
Rate Versus Rhythm Control for Atrial Fibrillation
Shin, E. D., Tran, H., Ramalingam, N. D., Liu, T., & Fan, E. (2023) · The Permanente Journal · doi:10.7812/tpp/23.151 · Cited by 6
Atrial Tachyarrhythmias Temporally Precede Fluid Accumulation in Implantable Device Patients
Andriulli, J. A., Moore, H. J., Hettrick, D. A., Ousdigian, K. T., Johnson, J. W., & Markowitz, S. M. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12309 · Cited by 6
The Value of Magnetic Resonance Imaging in Catheter Ablation of Atrial Fibrillation
Gu, J., Hu, W. G., & Liu, X. (2015) · Clinical Cardiology · doi:10.1002/clc.22360 · Cited by 6
Statins and atrial fibrillation in patients with left ventricular dysfunction: Insights from the AF-CHF trial
Koutbi, L., Roy, D., Talajic, M. R., Blondeau, L., Franceschi, F., Rivard, L., Macle, L., Andrade, J. G., Guerra, P. G., Thibault, B., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.033 · Cited by 6
Atrial Fibrillation Ablation and Heart Failure
Man, J. P., & Marchlinski, F. E. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0301-y · Cited by 6
Update on atrial fibrillation
Shenasa, M., Shenasa, H., & Soleimanieh, M. (2014) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2014.03.004 · Cited by 7
Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
Hohnloser, S. H. (2012) · Clinical Cardiology · doi:10.1002/clc.20959 · Cited by 6
The importance of interactions between atrial fibrillation and heart failure
Khan, M. A., Satchithananda, D. K., & Mamas, M. A. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-272 · Cited by 6
Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction
Wang, M., Cai, S., Ding, W. J., Deng, Y., & Zhao, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174510 · Cited by 6
Atrial Fibrillation Ablation and its Impact on Stroke
Graves, K. G., Jacobs, V., May, H. T., Cutler, M. J., Day, J. D., & Bunch, T. J. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0596-0 · Cited by 6
Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
Lai, K.-C., Chen, S., Lin, C., Yang, F., Lin, C., Hsu, C.-W., Huang, W.-C., & Kao, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00448 · Cited by 6
Comparative Therapeutic Assessment of Atrial Fibrillation in Heart Failure With Reduced Ejection Fraction—A Network Meta-Analysis
Malik, A. H., & Aronow, W. S. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000892 · Cited by 6
Rhythm versus rate control strategies regarding anticoagulant use in elderly non-valvular atrial fibrillation patients: Subanalysis of the ANAFIE (All Nippon AF In the Elderly) Registry
Yuzawa, H., Inoue, H., Yamashita, T., Akao, M., Atarashi, H., Koretsune, Y., Okumura, K., Shimizu, W., Tsutsui, H., Toyoda, Ḱ., et al. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.01.010 · Cited by 6
Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.
Of, H., Suwaidi, J. M. S. A., & Salam, A. M. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.864 · Cited by 6
Effect Of Catheter Ablation On Quality Of Life In Atrial Fibrillation.
Gonzalez, J., Macle, L., Deyell, M. W., Bennett, M. T., Dubuc, M., Dyrda, K., Guerra, P. G., Khairy, P., Mondesert, B. A., Rivard, L., et al. (2014) · PubMed Central · doi:10.4022/jafib.1063 · Cited by 6
Arrhythmia-Induced Cardiomyopathies
Dhawan, R., & Gopinathannair, R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-41967-7_24 · Cited by 6
Impact of exercise capacity on the long-term incidence of atrial arrhythmias in heart failure
Sakai, T., Yagishita, A., Morise, M., Sakama, S., Ijichi, T., Ayabe, K., Amino, M., Ikari, Y., & Yoshioka, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-98172-9 · Cited by 5
Impact of Rhythm vs. Rate Control in Atrial Fibrillation on the Long-Term Outcome of Patients Undergoing Transcatheter Edge-to-Edge Mitral Valve Repair
Waechter, C., Ausbuettel, F., Chatzis, G., Cheko, J., Fischer, D., NEF, H. M., Barth, S., Halbfaß, P., Deneke, T., Kerber, S., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215044 · Cited by 6
Actualización en cardiología geriátrica
Martínez‐Sellés, M., Datino, T., Dı́az-Castro, Ó., & López‐Palop, R. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70137-8 · Cited by 6
Atrial fibrillation ablation as first-line therapy for patients with heart failure with reduced ejection fraction (HFrEF): evaluating the impact on patient survival
Younes, H., Noujaim, C., Mekhael, M., Chouman, N., Assaf, A. Y. M., Kreidieh, O., Lim, C., Marrouche, N. F., & Donnellan, E. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2172402 · Cited by 6
Behandlung von Vorhofflimmern in der Intensiv- und Notfallmedizin
Arrigo, M., Béttex, D., & Rudiger, A. (2015) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-015-0006-2 · Cited by 6
Diabetes Mellitus and Metabolic Syndrome
Cosentino, F., Rydén, L., Francia, P., & Mellbin, L. (2009) · doi:10.1093/med/9780199566990.003.014 · Cited by 6
Tackling Patient-Reported Outcomes in Atrial Fibrillation and Heart Failure
Steinberg, B. A., & Piccini, J. P. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.01.013 · Cited by 7
Thirty‐day readmissions after atrial fibrillation catheter ablation in patients with heart failure
Lima, F. V., Kennedy, K. F., Sheikh, W., French, A. L., Parulkar, A. B., Sharma, E., Henien, S., Michael Shengtao, W. U., & Chu, A. F. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14013 · Cited by 6
Comorbidities in Heart Failure
Marı́n-Garcı́a, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_13 · Cited by 6
Delirium cordis: can we predict the onset of atrial fibrillation?
Brieger, D. B., & Freedman, B. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60415-3 · Cited by 6
Pathophysiology of atrial fibrillation: Insights into the renin–angiotensin system
Heuzey, J. L., Marijon, É., Chachoua, K., Waintraub, X., Lepillier, A., Otmani, A., Lavergne, T., & Pornin, M. (2008) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2008.09.015 · Cited by 6
Fine-Tuning a Heart-Brain Connection
Pozuelo, L. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.967778 · Cited by 6
Optimizing the treatment of atrial fibrillation: contributions by remote monitoring
Israel, C. W. (2008) · EP Europace · doi:10.1093/europace/eun355 · Cited by 6
Heart failure and atrial fibrillation: Can we break this nexus?
Chugh, S. S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.043 · Cited by 6
Cardiac Arrhythmias and Pregnancy
SPEARS, D. A., & Elkayam, U. (2019) · Wiley eBooks · doi:10.1002/9781119409861.ch15 · Cited by 6
Treatment of Arrhythmias During Pregnancy
Pacheco, L. D., Eyada, M., & Saade, G. R. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000747 · Cited by 5
2024 Guidelines of the Taiwan Society of Cardiology for the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction.
Li, Y., Wang, C., Hung, C., Wu, Y., Hsu, C., Tsou, Y., Wang, C., Wu, C., Lin, P., Chang, H., et al. (2024) · PubMed Central · doi:10.6515/acs.202403_40(2).20240206a · Cited by 5
Optogenetic modulation of cardiac autonomic nervous system
Hernandez-Dominguez, R. A., Herrera-Orozco, J. F., Salazar-Calderón, G. E., Chávez‐Canales, M., Márquez, M. F., González-Alvarez, F., Totomoch-Serra, A., Reyes-Cruz, T., Lip, F., & Buendia, J. D. J. A. (2024) · Autonomic Neuroscience · doi:10.1016/j.autneu.2024.103199 · Cited by 5
Effectiveness and safety of Liriope Tuber (Liriopis seu Ophiopogonis Tuber, Maidong) included traditional herbal medicine for patients with paroxysmal atrial fibrillation: A systematic review, meta-analysis, and network analysis
Jin, H., Kang, S., Park, D., Mun, Y., & Leem, J. (2024) · Integrative Medicine Research · doi:10.1016/j.imr.2024.101069 · Cited by 5
Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age
Haegeli, L., & Duru, F. (2011) · Cardiology Research and Practice · doi:10.4061/2011/854205 · Cited by 5
Early versus delayed cardioversion: why should we wait?
Airaksinen, J. K. E. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1736563 · Cited by 6
Chronic Amiodarone Use and the Risk of Cancer: A Systematic Review and Meta-analysis
Siemers, L. A., MacGillivray, J., Andrade, J. G., & Turgeon, R. D. (2020) · CJC Open · doi:10.1016/j.cjco.2020.09.013 · Cited by 5
Arrhythmia-Induced Cardiomyopathy
Jain, A. K., & Selvaraj, R. J. (2021) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620987975 · Cited by 5
The RACE to the EAST. In pursuit of rhythm control therapy for atrial fibrillation—a dedication to Harry Crijns
Reißmann, B., BREITHARDT, G. E., Camm, A. J., Gelder, I. C. V., Metzner, A., & Kirchhof, P. F. (2021) · EP Europace · doi:10.1093/europace/euab023 · Cited by 5
The Aged Heart
Magidson, P. D. (2022) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2022.06.004 · Cited by 6
Heart Failure with Reduced Ejection Fraction and Atrial Fibrillation: A Sub-Saharan African Perspective
Mboweni, N., Maseko, M. J., & Tsabedze, N. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14332 · Cited by 5
Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet
Crawford, M., Steinberg, B. A., Ranjan, R., Konstantinidis, K., Navaravong, L., & Bunch, T. J. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16160 · Cited by 5
Clinical characteristics and outcomes in super‐elderly patients (>85 years) with heart failure: single center observational study in J apan
Fujii, N., Naito, K., Nakahara, N., Nakano, A., & Takagi, S. (2014) · Acute Medicine & Surgery · doi:10.1002/ams2.23 · Cited by 5
Effect of catheter ablation on the left ventricular mass index and other echocardiograph parameters in atrial fibrillation patients: comparison with antiarrhythmic drug treatment
Kim, K., Na, J. O., Nam, G., Jin, E., Choi, H., Kim, S., Choi, K., & Kim, Y.-H. (2010) · Journal of Echocardiography · doi:10.1007/s12574-010-0069-2 · Cited by 5
Insuficiencia cardíaca aguda: factores desencadenantes y prevención
Bodas, Ó. A., Martel, A. C., & Bautista, P. S. (2014) · Medicina Clínica · doi:10.1016/s0025-7753(14)70076-4 · Cited by 7
Recent advances in management of atrial fibrillation in patients with heart failure
Shantsila, E., & Lip, G. Y. H. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835bd465 · Cited by 5
Atrial Fibrillation and Stroke: The Evolving Role of Rhythm Control
Patel, T. K., & PASSMAN, R. S. (2013) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-013-0234-9 · Cited by 5
Challenging the status quo: β-blockers for HF plus AF
Khairy, P., & Roy, D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.166 · Cited by 5
Pulmonary Vein Isolation for the Treatment of Atrial Fibrillation: Past, Present and Future
de Waroux, J. L. P., Talajic, M. R., Khairy, P., Guerra, P. G., Roy, D., Thibault, B., Dubuc, M., & Macle, L. (2009) · Future Cardiology · doi:10.2217/fca.09.55 · Cited by 6
Catheter ablation for atrial fibrillation: a promising therapy for congestive heart failure
Patel, D., Natale, A., Biase, L. D., Burkhardt, J. D., Wang, Y., Sánchez, J., Horton, R., & Khan, M. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.61 · Cited by 5
Atrial fibrillation 3: management
Cottrell, C. (2012) · Practice Nursing · doi:10.12968/pnur.2012.23.3.120 · Cited by 5
Atrial fibrillation and heart failure
Garg, A., & AKOUM, N. W. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835fb710 · Cited by 5
Does heart rate really matter to patients with heart failure?
Miller, R. J. H., & Howlett, J. G. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000368 · Cited by 8
Rhythm and rate control of atrial fibrillation in the emergency department – A large community-based observational study
Gilbert, C. J., Angaran, P., Mariano, Z., Aves, T., & Dorian, P. (2017) · Canadian Journal of Emergency Medicine · doi:10.1017/cem.2017.421 · Cited by 5
Impact of Evolving Comorbidities on Outcomes After Catheter Ablation of Atrial Fibrillation in the United States Between 2003 and 2013
Kim, L. K., Yeo, I., Cheung, J. W., Feldman, D. N., Swaminathan, R. V., & Kamel, H. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.12.014 · Cited by 5
Rhythm Control of Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
Burkman, G. M., & Naccarelli, G. V. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01336-8 · Cited by 5
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.
Chourdakis, E., Koniari, I. C., Velissaris, D., Tsigkas, G., Kounis, N., & Osman, N. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.05.008 · Cited by 6
Impact of catheter ablation for atrial fibrillation in patients with heart failure and left ventricular systolic dysfunction
Ribeiro, J. M., Sousa, P. A., António, N., Baptista, R., Elvas, L., Barra, S., & Gonçalves, L. M. M. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2020.08.014 · Cited by 5
Variation in Heart Rate Range by 24-h Holter Monitoring Predicts Heart Failure in Patients with Atrial Fibrillation
Oikawa, J., Fukaya, H., Ishii, S., Nabeta, T., Nakamura, H. K., Ishizue, N., Kitasato, L., Kishihara, J., Yamaoka‐Tojo, M., Niwano, S., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14035 · Cited by 5
Approach to atrial fibrillation
Bell, A., Andrade, J. G., Macle, L., Connelly, K. A., LaBine, L., & Singer, A. G. (2023) · Canadian Family Physician · doi:10.46747/cfp.6904245 · Cited by 5
Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias
Ray, L., Geier, C., & DeWitt, K. M. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad108 · Cited by 6
Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry
Bucci, T., Nabrdalik, K., Shantsila, A., Romiti, G. F., Teo, W. S., Park, H. W., Shimizu, W., Tse, H., Proietti, M., Chao, T., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051274 · Cited by 5
Changing the Paradigm to Understand and Manage Atrial Fibrillation
Dan, G. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5475-4_6 · Cited by 7
Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial.
Shojaee, M., Feizi, B., Miri, R., Etemadi, J., & Feizi, A. H. (2017) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v5i1.153 · Cited by 5
California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE)
Srivatsa, U. N. (2018) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2036 · Cited by 5
Atrial Fibrillation in Patients with Ischemic and Non-Ischemic Left Ventricular Dysfunction.
Ducas, R., & Ariyarajah, V. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.535 · Cited by 5
Pathophysiology of Heart Failure
Velez, M., & Sweitzer, N. K. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-424-7_1 · Cited by 5
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial
Botto, G. L., Boriani, G., Favale, S., Landolina, M., Molon, G., Tondo, C., Biffi, M., Grandinetti, G., Filippo, P. D., Raciti, G., et al. (2011) · Trials · doi:10.1186/1745-6215-12-44 · Cited by 5
Management of atrial fibrillation in the acute setting
Chenoweth, J., & Diercks, D. B. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328354dc30 · Cited by 5
Antiarrhythmic drugs for atrial fibrillation
Marinelli, A., & Capucci, A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.554400 · Cited by 5
Modification of cardiovascular ion channels by gene therapy
Télémaque, S., & Marsh, J. D. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.76 · Cited by 5
Atrial fibrillation practice patterns among cardiac electrophysiologists and cardiologists
Teme, T., & Goldberger, J. J. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0089 · Cited by 5
Atrial Fibrillation and Stroke in Elderly Patients
Dang, G., Jahangir, I. A., Sra, J. S., Tajik, A. J., & Jahangir, A. (2016) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1409 · Cited by 5
Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.
Sharma, P. S., & Callans, D. J. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.740 · Cited by 5
The Year in Heart Failure
Tang, W. H. W., & Francis, G. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.026 · Cited by 5
Heart Failure
McMurray, J. J. V., Petrie, M. C., Swedberg, K. B., Michel Komajda, N., Anker, S. D., & Gardner, R. S. (2009) · doi:10.1093/med/9780199566990.003.023 · Cited by 6
New Pharmacological Options for Patients With Atrial Fibrillation: The ATHENA Trial
Hohnloser, S. H. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)71829-8 · Cited by 5
Undetected paroxysmal atrial fibrillation in chronic heart failure patients: is it clinically relevant to catch the atrial phantom?
Pisters, R., de Vos, C. B., Dennert, R. M., & Crijns, H. J. G. M. (2009) · EP Europace · doi:10.1093/europace/eup268 · Cited by 5
Risk of Catheter Ablation for Atrial Fibrillation
Corrado, D., & Zorzi, A. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.07.002 · Cited by 5
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population
Patel, P. J., & Ahmed, A. S. (2023) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2026.03.001 · Cited by 4
Comparison of rhythm versus rate control of atrial fibrillation in heart failure subgroups: Systematic review and meta-analysis of randomized controlled trials
Siddiqi, R. L., Fares, A., Mahmoud, M., Asghar, K., Assaly, R., Eltahawy, E. A., Grubb, B. P., & Moukarbel, G. V. (2024) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2024.09.004 · Cited by 4
Relaxin-2 Exhibits a Beneficial Role in Energy Metabolism to Alleviate Atrial Fibrillation Susceptibility
Zhao, X., Cao, Y., Gao, Q., Han, X., Zhang, H., Mu, H., Zhang, S., Wang, X., Li, Y., & Yuan, Y. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00354 · Cited by 4
Propafenone‐ vs . amiodarone‐associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure
Lin, Y., Chen, B., Hsu, C., Chen, L., Lin, S., Lip, G. Y. H., Chien, L., & Huang, C. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70068 · Cited by 4
Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis
Toso, E., Peyracchia, M., Matta, M., D’Ascenzo, F., Gaïta, F., Kornej, J., Hindricks, G., Bunch, T. J., & Saliba, W. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.082 · Cited by 4
2018 Korean Guidelines for Catheter Ablation of Atrial Fibrillation: Part I
Park, H., Jeong, D. S., Yu, H. T., Pak, H., Uhm, J., Kim, J. Y., Kim, J., Lee, J., Kim, K. H., Roh, S., et al. (2018) · International Journal of Arrhythmia · doi:10.18501/arrhythmia.2018.011 · Cited by 4
Symptom management strategies: Rhythm vs rate control in patients with atrial fibrillation in the Balkan region: Data from the BALKAN‐AF survey
Kozieł, M., Mihajlovic, M., Nedeljkovic, M. A., Pavlović, N., Paparisto, V., Musić, L., Trendafilova, E., Dan, A. R., Kušljugić, Z., Dan, G., et al. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14080 · Cited by 4
Fibrilação Atrial (Parte 2) – Ablação por Cateter
Saad, E., & d’Ávila, A. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200477 · Cited by 6
Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
Koniari, I. C., Artopoulou, E., Velissaris, D., Mplani, V., Anastasopoulou, M., Kounis, N. G., GREGORIO, C. D., Tsigkas, G., Karunakaran, A., Plotas, P., et al. (2022) · Medicina · doi:10.3390/medicina58060743 · Cited by 5
Impact of an Organized Treatment Pathway on Management of Atrial Fibrillation
Lakkireddy, D., Ahmed, A., Bawa, D., Garg, J., Atkins, D., Kabra, R., Pham, N. K., Bernholtz, J., Darden, D. J., Bommana, S., et al. (2024) · JACC Advances · doi:10.1016/j.jacadv.2024.100905 · Cited by 4
Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
Okhotin, A., Osipov, M., Osipov, V., & Барчук, А. А. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03885-0 · Cited by 4
Influence of time to ablation on outcomes among patients with atrial fibrillation with pre-existing heart failure
Lador, A., Maccioni, S., Khanna, R., & Zhang, D. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.07.016 · Cited by 4
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB study
Pokorney, S. D., Nemeth, H., Chiswell, K., Albert, C. M., Allyn, N., Blanco, R. G., Butler, J., Calkins, H. G., Elkind, M. S. V., Fonarow, G. C., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.10.001 · Cited by 4
Inflammation and risk of cardiovascular outcomes in patients with atrial fibrillation and flutter: A nationwide registry study
Langhoff, A. C. F., Modin, D., Dons, M., Skaarup, K. G., Sengeløv, M., Borchsenius, J., Gislason, G., Wisborg, F. D., Hove, J. D., Lindhardt, T. B., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.051 · Cited by 4
Reviewing the use of antiarrhythmic drugs in elderly patients with atrial fibrillation
Menichelli, D., Gazzaniga, G., Malatesta, D., Carlo, G. D., Brogi, T., Pani, A., Pignatelli, P., & Pastori, D. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2561717 · Cited by 4
Is there a heart rate paradox – demystification of the myths?
KJEKSHUS, J. K. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02143.x · Cited by 4
Long term treatment of atrial fibrillation in elderly patients: A decision analysis
Lafuente‐Lafuente, C., Emery, C., Laurendeau, C., Fagnani, F., & Bergmann, J. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.130 · Cited by 4
Current Approaches to Antiarrhythmic Therapy in Heart Failure
Rose‐Jones, L. J., Bode, W. D., & Gehi, A. K. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.07.010 · Cited by 6

Authors: Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., & Waldo, A. L.
Affiliations: Montreal Heart Institute (CA)
Libin Cardiovascular Institute of Alberta (CA)
St. Michael's Hospital (CA)
Duke Medical Center (US)
London Health Sciences Centre (CA)
Rhode Island Hospital (US)
St George's Hospital (GB)
Population Health Research Institute (CA)
Goethe University Frankfurt (DE)
Bispebjerg Hospital (DK)
VA West Los Angeles Medical Center (US)
Brigham and Women's Hospital (US)
University Hospitals Cleveland Medical Center (US)
ORCID: Roy, Denis
Talajic, Mario
Nattel, Stanley
Dorian, Paul
Bourassa, Martial G.
Buxton, Alfred E.
Camm, A. John
Connolly, Stuart J.
Ducharme, Anique
Guerra, Peter G.
Hohnloser, Stefan H.
Lambert, Jean
Pedersen, Ole Dyg
Rouleau, Jean-Lucien
Stevenson, Lynne Warner
Stevenson, William G.
Thibault, Bernard
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-06-19
Volume: 358
Issue: 25
Pages: 2667-2677
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0708789
OpenAlex: W2131260805
Cited by: 1,585
References: 41
Citations by year: 2026: 42 · 2025: 33 · 2024: 69 · 2023: 55 · 2022: 76 · 2021: 86 · 2020: 77 · 2019: 82 · 2018: 96 · 2017: 87 · 2016: 73 · 2015: 75 · 2014: 87 · 2013: 123 · 2012: 114
FWCI: 97.76
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: atrial fibrillation, heart failure, rhythm control, rate control, sinus rhythm maintenance, ventricular rate control, cardiovascular mortality, congestive heart failure, stroke, worsening heart failure, left ventricular ejection fraction
MeSH terms: Adrenergic beta-Antagonists, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Atrial Fibrillation, Cardiovascular Diseases, Combined Modality Therapy, Digitalis Glycosides, Electric Countershock, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Ventricular Dysfunction, Left, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks